China’s vitamin market remains sluggish, with most categories experiencing softening prices.

In the European market, different categories are exhibiting varying price dynamics. Prices for Lysine varieties have softened, and Tryptophan prices remain weakly stable. As for Methionine,

In the European market, Vitamins A, E, and D3 were the primary topics of discussion this week.

This week, the Dicalcium Phosphate market has maintained high-level consolidation. Traders gradually raised their bottom prices amid a stalemate between upstream and downstream sectors.

On March 25th, 2025, Zhejiang Garden Biopharmaceutical Co., Ltd. announced its 2024 Annual Report, achieving RMB 1,243.2832 million of operation revenues in 2024, up 13.58% year-on-year.

During the 11th week of 2025, inquiries on Mobaobuy.com increased by 65.4%, while transaction value surged by 168.2% compared to the previous week. The conversion rate dropped to 59.1%.

The Chinese amino acid market has performed flatly, with downstream users adhering to demand-driven procurement practices amid a strong wait-and-see mood.

China’s vitamin market is currently characterized by calm trading activity, with prices for most categories holding steady.